Dr. Manish Shah (Manish A. Shah) joined me for our annual #CancerCast tradition of discussing the most practice-changing #research presented at the 2023 ASCO meeting. Listen in as we break down what this research means for patients: bit.ly/3DG61Lq #ASCO23

Join Weill Cornell Medicine #SkinCancer experts Drs. Anna Pavlick, Christina Del Guzzo and Barbara Ma tomorrow 8/22 for a webinar in conjunction with the Skin Cancer Education & Research Foundation on living with non-melanoma skin cancer. Register here: bit.ly/3sls9sg

It’s not too late to register for tonight’s non-melanoma #SkinCancer symposium. Weill Cornell Medicine experts will discuss identifying these types of skin cancer, treatment options, and the latest clinical #research: bit.ly/3sls9sg

#CutaneousOncology expert and Weill Cornell Medicine Meyer Cancer Center Director Dr. Jedd Wolchok spoke with CURE Today about the use of #immunotherapy for #SkinCancer: bit.ly/45okOa8

Dr. Anna Pavlick weighs in on the use of #Immunotherapy as a treatment for #Melanoma, as well as #SkinCancer risk factors patients should be aware of: bit.ly/3QaXqqa (cc: SurvivorNet)

Dr. Anna Pavlick, co-chair of the Society for Immunotherapy of Cancer Melanoma Immunotherapy Guideline Expert Panel, helped develop an update to the 2018 SITC #Melanoma clinical practice guideline which covers #immunotherapy indications for cutaneous melanoma: bit.ly/3GFnhCg

Dr. Jedd Wolchok spoke with The Wall Street Journal about balancing whether to stop or continue #immunotherapy treatment for #cancer: bit.ly/4aVKy0D

WATCH: Dr. Anna Pavlick discusses understanding #immunotherapy side effects and how this type of treatment works for #Melanoma bit.ly/41ZZO8w (cc: SurvivorNet)

Dr. Jedd Wolchok weighs in on the ability to use #immunotherapy, such as immune checkpoint inhibitors, to predict #Melanoma patient responses to treatment: bit.ly/3RSM2zO

#Cancer can have a big impact on #BoneHealth. In this episode of #CancerCast, Penny Andreopoulou breaks down everything patients need to know about the connection between the bones and cancer, incl. how diagnosis & treatment can directly affect bone strength bit.ly/3vrQcYt

#DYK that #Pathology supplies a majority of a medical record? On #CancerCast, Dr. Amy Chadburn of Weill Cornell Medicine Pathology explains the role pathologists play in #cancer care to help solid tumor & #BloodCancer patients get accurate diagnoses and treatment plans: bit.ly/3JF7ViE

Our Weill Cornell Medicine NewYork-Presbyterian Dermatology colleague Dr. Niroshana Anandasabapathy (Niro Anandasabapathy) explains how advancements in detection and treatment are improving #Melanoma outcomes: bit.ly/4b7laEV #MelanomaMonday (cc: Targeted Oncology)

This #SkinCancerAwarenessMonth, join Weill Cornell Medicine NewYork-Presbyterian experts for a webinar on #Melanoma awareness. Learn how to prevent, detect, and manage this form of #SkinCancer:  bit.ly/3QN82MY

This #ClinicalTrialsDay, team members Weill Cornell Medicine NewYork-Presbyterian highlight how we’re making a difference through #ClinicalTrials. So proud of the #ClinicalResearch and behind-the-scenes teamwork moving the field forward. Thanks to all the volunteers who participate in #research!

Paul Chapman, MD will be reviewing three abstracts as part of a #Melanoma/#SkinCancer oral abstract session this afternoon at #ASCO24: bit.ly/3yPiKw7

#ASCO24 kicks off today! We’re excited to join our colleagues from across Weill Cornell Medicine at this year’s ASCO meeting.

TODAY: Our Weill Cornell Medicine Meyer Cancer Center director Dr. Jedd Wolchok is chairing and presenting during an #ASCO24 education session on the future of #Melanoma treatment later today. More details: bit.ly/454RTbE

#cutaneousoncology minus Jedd Wolchok Weill Cornell Medicine Meyer Cancer Center #ASCO2024 #gicancersuseimmunotherapytoo WCM Cutaneous Oncology

Our Weill Cornell Medicine Meyer Cancer Center director Dr. Jedd Wolchok (Jedd Wolchok) reflected on study data presented at #ASCO24 that suggested sandwich therapy may not be necessary in #Melanoma patients who respond to neoadjuvant therapy: bit.ly/4c9j6MB

Our ASCO #CancerCast tradition continues! Dr. Manish Shah (Manish A. Shah) joined me for our annual episode where we delve into the most exciting #ASCO24 #research. From #AI to #immunotherapy & #BiTes, we break down what patients and loved ones should know bit.ly/3WNlPql